The explosive growth in semaglutide (Ozempic and Wegovy) We use after its FDA approval for chronic weight management in 2021 was accompanied by another trend that drew researchers' attention: a dramatic increase in calls to poison control centers across the United States.
Jordan Miller, then an undergraduate student at UT San Antonio, wanted to find out whether the surge in poison control cases was directly connected to the FDA's expanded approval of semagluti...

4 days ago
17








English (US) ·